Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer - 08/05/15
, Zhijun Dai, Li Ma, Yaofeng Jin, Xijing WangBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Background |
Insulin-like growth factor binding protein 3 (IGFBP3) plays an important role in cellular proliferation, differentiation, apoptosis, and mammary carcinogenesis. Genetic variations in IGFBP3 have been identified to influence the circulating IGFBP3 level. The present study determined the impact of an important promoter polymorphism (A-202C, rs2854744) on susceptibility and progression of breast cancer in a Chinese population.
Methods |
We genotyped the IGFBP3 A-202C polymorphism in a case-control study involving 465 breast cancer patients and 799 age-matched, cancer-free controls using the TaqMan method. Logistic regression was used to assess the genetic association between the occurrence and progression of breast cancer.
Results |
Compared with the wild genotype (-202AA), we found a statistically significant increased risk of breast cancer associated with the variant genotypes (CC vs. AA: OR=2.00, 95% CI=1.25–3.21; AC+CC vs. AA: OR=1.34, 95% CI=1.06–1.70). In the stratified analysis, the increased risk was more apparent among the subgroups of older subjects (OR=1.70, 95% CI=1.20–2.42). Furthermore, we found that patients carrying variant genotypes (AC+CC) had a significantly greater prevalence of large tumor size (OR=1.72, 95% CI=1.13–2.64; P=0.021).
Conclusion |
Our results suggest that the functional IGFBP3 A-202C polymorphism may influence the susceptibility and progression of breast cancer in the Chinese population.
Le texte complet de cet article est disponible en PDF.Keywords : IGFBP3, Polymorphism, Breast cancer, Susceptibility, Progression
Plan
Vol 71
P. 108-111 - avril 2015 Retour au numéro
Article précédent
- The effect of sodium bicarbonate on cytokine secretion in CKD patients with metabolic acidosis
- Yaacov Ori, Boris Zingerman, Michael Bergman, Hanna Bessler, Hertzel Salman
- miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression
- Junhua Wei, Xuchen Qi, Qitao Zhan, Daoyang Zhou, Qingfeng Yan, Yirong Wang, Lianjie Mo, Yingfeng Wan, Dajiang Xie, Jixi Xie, Shuxu Yang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?